![](/img/cover-not-exists.png)
954PSPAZO2 (SOGUG): Outcomes and prognostic significance of IMDC intermediate prognosis subclassification in metastatic renal cell carcinoma (mRCC) in patients treated with 1st-line pazopanib (1stPz)
Valderrama, B P, Perez Ramirez, S, Rodriguez-Vida, A, González del Alba, A, Mendez Vidal, M J, Vazquez Estevez, S, Martinez Ortega, E, Virizuela, J A, Fernández Calvo, O, Hernández Jorge, A, Vazquez MVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.050
Date:
October, 2019
File:
PDF, 93 KB
2019